Millions of dementia patients may actually have 'very treatable' liver disease that has been misdiagnosed, according to 'unexpected' study
A new study of US veterans diagnosed with dementia found that many of them had liver disease, suggesting millions of people diagnosed with dementia could actually have a treatable condition. (Source: the Mail online | Health)
Source: the Mail online | Health - March 12, 2024 Category: Consumer Health News Source Type: news
Alcohol-Associated Liver Disease On the Rise: What to Know Alcohol-Associated Liver Disease On the Rise: What to Know
Dr Nancy Reau speaks with hepatologist Dr Ashwani Singal about how to identify alcohol-associated liver disease, the most common cause of advanced hepatic disease worldwide.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 11, 2024 Category: Gastroenterology Tags: Gastroenterology Expert Interview Source Type: news
Millions of dementia patients my actually have 'very treatable' liver disease that has been misdiagnosed, according to 'unexpected' study
A new study of US veterans diagnosed with dementia found that many of them had liver disease, suggesting millions of people diagnosed with dementia could actually have a treatable condition. (Source: the Mail online | Health)
Source: the Mail online | Health - March 9, 2024 Category: Consumer Health News Source Type: news
Semaglutide Cuts Liver Disease Severity in People With HIV
(MedPage Today) -- DENVER -- Semaglutide (Ozempic) reduced the amount of liver fat by nearly a third in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), the open-label phase IIb SLIM LIVER study showed.
In... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 9, 2024 Category: Gastroenterology Source Type: news
Ozempic Eases Fatty Liver Disease in People Living With HIV
THURSDAY, March 7, 2024 -- There ' s more good news around the diabetes and weight-loss drug Ozempic: It might help ease fatty liver disease in people living with HIV, new research shows.Six months of weekly injections of Ozempic (semaglutide)... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 7, 2024 Category: General Medicine Source Type: news
Semaglutide reduces severity of common liver disease in people with HIV
NIH-funded findings inform interdisciplinary care approach across the lifespan. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - March 5, 2024 Category: American Health Source Type: news
2 Bay Area biotechs look to raise collective $550 million following deal, trial news
Akero disclosed midstage trial data Monday for its treatment for the fatty liver disease MASH, while BridgeBio announced a deal Sunday to license its heart failure drug to Bayer in Europe. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 4, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Akero's Fatty Liver Disease Drug Lessens Scarring in Mid-stage Trial Akero's Fatty Liver Disease Drug Lessens Scarring in Mid-stage Trial
Akero Therapeutics ' experimental drug for a type of fatty liver disease significantly reduced scarring after nearly two years in a mid-stage study, it said on Monday, as the...Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 4, 2024 Category: Pathology Tags: Gastroenterology Source Type: news
Symptoms of fatty liver disease to spot as condition linked to higher dementia risk
Around one in three adults in the UK is thought to be living with the early stages of fatty liver disease. (Source: Daily Express - Health)
Source: Daily Express - Health - March 3, 2024 Category: Consumer Health News Source Type: news
Zydus aims to launch first new drug in US by early 2026
Zydus will enter a competitive field, with an FDA decision on CymaBay's PBC drug due in August. Gilead Sciences announced its acquisition of CymaBay for $4.3 billion earlier in February. Saroglitazar, currently in a mid-to-late-stage trial for PBC, is also being tested for Metabolic Dysfunction-Associated Steatohepatitis (MASH), a type of fatty liver disease." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news
Can GLP-1 Agonists Reduce Risk for Severe Liver Disease? Can GLP-1 Agonists Reduce Risk for Severe Liver Disease?
GLP-1 agonists could be a treatment option to reduce the risk for major adverse liver outcomes in adults with type 2 diabetes and chronic liver disease.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 23, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news
'I'm a gastroenterologist - follow these steps to reverse fatty liver disease'
Sticking to these rules could see your liver health improve in a matter of just weeks. (Source: Daily Express - Health)
Source: Daily Express - Health - February 22, 2024 Category: Consumer Health News Source Type: news
Alcohol-Related Liver Disease Mortality Higher in Women Alcohol-Related Liver Disease Mortality Higher in Women
Despite lower prevalence rates, women with steatotic liver disease related to alcohol consumption had close to double the risk of dying than men with the same condition.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 22, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news
Tharimmune's Oral'Under The Cheek' Candidate At Par With FDA-Approved Injectable With Potential For Chronic Liver Disease
Tuesday, Tharimmune Inc THAR completed its Phase 1 clinical trial with TH104, a proprietary transmucosal buccal film embedded with the approved, active compound nalmefene, which easily adheres inside of the mouth on the cheek and biodegrades within minutes. TH104 is designed to avoid the liver’s…#tharimmuneincthar #phase1 #th104 #fda #tharimmune #thar (Source: Reuters: Health)
Source: Reuters: Health - February 20, 2024 Category: Consumer Health News Source Type: news
'I’m a liver specialist - here's the number one common symptom of fatty liver disease'
Around a third of adults in the UK are thought to have the early stages of fatty liver disease. (Source: Daily Express - Health)
Source: Daily Express - Health - February 20, 2024 Category: Consumer Health News Source Type: news
